migraine treatment

Healthcare professionals in a consultation

Click Therapeutics granted FDA market authorization for digital migraine drug

By Anthony Vecchione 03:34 pm April 15, 2025

Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines. The de novo classification is for the company’s CT-132 offering, for which it received FDA Breakthrough Device Designation in 2022. CT-132 is intended for the preventive treatment of episodic migraines in patients 18...

German startup Perfood closes €5M Series A for migraine therapy

By Sara Mageit 06:15 am December 3, 2020

German digital therapeutic startup, Perfood, has received €5 million in a Series A funding round to launch its first prescription therapeutic sinCephalea for the treatment of migraines and to prepare for the expansion of the technology into other countries. This includes the conduction of clinical studies to advance its digital therapeutics products. Boehringer Ingelheim Venture Fund led the...